REGULATORY

• Is Legal Regulation Necessary? Clinical Research at Turning Point 2: Prof. Kageyama of Jikei Univ.
  July 18, 2014

• MOF Official in Charge of Health Spending to “Carefully” Discuss Budgets
  July 17, 2014

• Council OKs Public-Knowledge Based Application for Oxaliplatin at Doses Approved Overseas
  July 16, 2014

• 50% Price Rule, Unifying Price Brackets Starters of Next Generic Price Revision Discussions: Ministry Official
  July 15, 2014

• MHLW Panel to Elaborate Proposed Scheme to Broaden Drug Development Requests
  July 15, 2014

• Editor’s Pick: Five Healthcare News Headlines for June 30 - July 11
  July 14, 2014

• Revised PAL to Go Live on November 25: Ministry Exec
  July 14, 2014

• Science Ministry’s Updated Guidelines to Require Research Data Preservation
  July 14, 2014

• Draft Policy on Resource Allocation Focuses Funding on 9 Fields of Healthcare R&D
  July 14, 2014

• Is Legal Regulation Necessary? Clinical Research at Turning Point 1: TRI Director Fukushima
  July 14, 2014

• Unami Tapped as New Budget Examiner for Health Finances
  July 11, 2014

• PFSB Announces Final Draft of Drug Interaction Guidelines
  July 11, 2014

• Utsunomiya to Move to National Center for Global Health and Medicine
  July 10, 2014

• MHLW Orders Revisions of Precaution Statements for a Number of Drugs Including Forteo and Paxil
  July 10, 2014

• MHLW Releases Report on Medical Database Project
  July 9, 2014

• Doctors at Ryukaikon Council Request Mandatory Inclusion of Expiry Dates in Product Barcodes
  July 8, 2014

• MHLW OKs IFN-Free Hepatitis C Treatments
  July 8, 2014

• Keiya Iida of METI to Be First “Councilor for the Promotion of Pharmaceutical and Related Industries”: MHLW
  July 8, 2014

• Kiyohito Nakai to Be Appointed Pharmaceutical Management Director
  July 8, 2014

• Ryukaikon Council Member Requests Rewards instead of Penalties for Early Delivery Price Settlements
  July 7, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 323
• 324
• 325
• 326
• 327
• 328
• 329
• 330
• 331
• …
• Next ›
• 最終 »